Fount Bio
Biopolymer-Based Products | Bioorthogonal Chemistry
- Business Model
- B2B
- Website
- fountbio.com
- Total Funding
- $8.2M
- Last Round
- $8.2M Series AJul 2021
- Rounds
- 1
About
Life science company developing glycopolymer-based products for tissue revitalization.
Summary
Fount Bio is a Biotech company. It has raised $8.2M in total across 1 round, most recently a $8.2M Series A round in Jul 2021. Investors include Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...